发明名称 |
Modulation of airway inflammation in patients with cystic fibrosis and related diseases |
摘要 |
This invention provides a method for treating pulmonary disease in patients with cystic fibrosis, variant cystic fibrosis, and non-cystic fibrosis bronchiectasis. The method involves administering a pharmaceutically effective amount of a lipoxin or lipoxin analogue to subjects with cystic fibrosis or related disease, in amounts sufficient to downregulate harmful neutrophilic airway inflammatory responses.
|
申请公布号 |
US2005113443(A1) |
申请公布日期 |
2005.05.26 |
申请号 |
US20040858840 |
申请日期 |
2004.06.01 |
申请人 |
KARP CHRISTOPHER L.;PETASIS NICOS A. |
发明人 |
KARP CHRISTOPHER L.;PETASIS NICOS A. |
分类号 |
A61K31/202;A61K31/232;A61K31/335;A61K31/38;A61P11/00;(IPC1-7):A61K31/38 |
主分类号 |
A61K31/202 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|